SCH-900105 in Recurrent Glioblastoma
NCT01189513
·
clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
Sponsor decision.
Conditions
Glioblastoma
Interventions
DRUG:
SCH 900105
Sponsor
M.D. Anderson Cancer Center
Collaborators
[object Object]